Charles River Labs Intl Stock
Charles River Labs Intl Stock
The price for the Charles River Labs Intl stock decreased slightly today. Compared to yesterday there is a change of -€2.000 (-0.870%).
Pros and Cons of Charles River Labs Intl in the next few years
Pros
?
M***** P*******
?
S********** s********
?
B****
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Charles River Labs Intl vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Charles River Labs Intl | -0.870% | 13.717% | 14.335% | 79.860% | 33.970% | 24.055% | -33.534% |
| Ligand Pharmaceuticals | -3.820% | -0.781% | -9.286% | 117.094% | 53.012% | 319.835% | 171.194% |
| United Therapeutics | -0.580% | 3.809% | -5.572% | 81.464% | 9.057% | 115.541% | 156.044% |
| Ionis Pharmaceuticals Inc. | 1.990% | 8.773% | -35.384% | 39.931% | -28.119% | 37.451% | 47.985% |
Comments
Charles River Laboratories International (CRL) had its "overweight" rating reaffirmed by Morgan Stanley.
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (CRL) had its "overweight" rating reaffirmed by Barclays PLC.
Show more
Ratings data for CRL provided by MarketBeat
Charles River Laboratories International (CRL) had its "outperform" rating reaffirmed by Evercore Inc.
Show more
Ratings data for CRL provided by MarketBeat